These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37692063)
1. Exploring rigid-backbone protein docking in biologics discovery: a test using the DARPin scaffold. Gaudreault F; Baardsnes J; Martynova Y; Dachon A; Hogues H; Corbeil CR; Purisima EO; Arbour M; Sulea T Front Mol Biosci; 2023; 10():1253689. PubMed ID: 37692063 [TBL] [Abstract][Full Text] [Related]
2. Computational Modeling of Designed Ankyrin Repeat Protein Complexes with Their Targets. Radom F; Paci E; Plückthun A J Mol Biol; 2019 Jul; 431(15):2852-2868. PubMed ID: 31082438 [TBL] [Abstract][Full Text] [Related]
3. Conformational flexibility of an anti-IL-13 DARPin†. Teplyakov A; Malia TJ; Obmolova G; Jacobs SA; O'Neil KT; Gilliland GL Protein Eng Des Sel; 2017 Jan; 30(1):31-37. PubMed ID: 27881684 [TBL] [Abstract][Full Text] [Related]
4. MutDock: A computational docking approach for fixed-backbone protein scaffold design. Chauhan VM; Pantazes RJ Front Mol Biosci; 2022; 9():933400. PubMed ID: 36106019 [TBL] [Abstract][Full Text] [Related]
5. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography. Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode. Veesler D; Dreier B; Blangy S; Lichière J; Tremblay D; Moineau S; Spinelli S; Tegoni M; Plückthun A; Campanacci V; Cambillau C J Biol Chem; 2009 Oct; 284(44):30718-26. PubMed ID: 19740746 [TBL] [Abstract][Full Text] [Related]
7. Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope. Azoitei ML; Ban YE; Julien JP; Bryson S; Schroeter A; Kalyuzhniy O; Porter JR; Adachi Y; Baker D; Pai EF; Schief WR J Mol Biol; 2012 Jan; 415(1):175-92. PubMed ID: 22061265 [TBL] [Abstract][Full Text] [Related]
8. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display. Schilling J; Schöppe J; Plückthun A J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107 [TBL] [Abstract][Full Text] [Related]
9. Design, construction, and characterization of a second-generation DARP in library with reduced hydrophobicity. Seeger MA; Zbinden R; Flütsch A; Gutte PG; Engeler S; Roschitzki-Voser H; Grütter MG Protein Sci; 2013 Sep; 22(9):1239-57. PubMed ID: 23868333 [TBL] [Abstract][Full Text] [Related]
10. Rapid refinement of protein interfaces incorporating solvation: application to the docking problem. Jackson RM; Gabb HA; Sternberg MJ J Mol Biol; 1998 Feb; 276(1):265-85. PubMed ID: 9514726 [TBL] [Abstract][Full Text] [Related]
11. A designed ankyrin repeat protein evolved to picomolar affinity to Her2. Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328 [TBL] [Abstract][Full Text] [Related]
13. BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures. Bolia A; Gerek ZN; Ozkan SB J Chem Inf Model; 2014 Mar; 54(3):913-25. PubMed ID: 24380381 [TBL] [Abstract][Full Text] [Related]
14. Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment. Isfahani MB; Mahnam K; Seyedhosseini-Ghaheh H; Sadeghi HMM; Khanahmad H; Akbari V; Varshosaz J Res Pharm Sci; 2023 Dec; 18(6):626-637. PubMed ID: 39005564 [TBL] [Abstract][Full Text] [Related]
15. Epitopes of Protein Binders Are Related to the Structural Flexibility of a Target Protein Surface. Kim DG; Choi Y; Kim HS J Chem Inf Model; 2021 Apr; 61(4):2099-2107. PubMed ID: 33829791 [TBL] [Abstract][Full Text] [Related]
16. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5. Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744 [TBL] [Abstract][Full Text] [Related]
17. Structural Basis for the Selective Inhibition of c-Jun N-Terminal Kinase 1 Determined by Rigid DARPin-DARPin Fusions. Wu Y; Honegger A; Batyuk A; Mittl PRE; Plückthun A J Mol Biol; 2018 Jul; 430(14):2128-2138. PubMed ID: 29126898 [TBL] [Abstract][Full Text] [Related]
18. Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo. Xia J; Gao G; Zhang C; Ying J; Li J Eur J Pharm Sci; 2023 Jun; 185():106422. PubMed ID: 36906110 [TBL] [Abstract][Full Text] [Related]